首页 > 最新文献

Innovative Surgical Sciences最新文献

英文 中文
Immunotherapy as a new perspective for the therapy of esophageal cancer. 免疫疗法作为食管癌治疗的新前景。
IF 1.7 Q2 SURGERY Pub Date : 2024-09-09 eCollection Date: 2025-03-01 DOI: 10.1515/iss-2023-0023
Yvonne Huber, Markus Moehler, Anica Högner

The therapeutic landscape in nearly every therapeutic line in advanced/metastatic patients with squamous cell carcinoma (SCC) and esophagogastric adenocarcinoma (EGC) is enriched by recent approvals of immune checkpoint inhibitors (ICIs). In curative intended therapy, patients without pathological residual disease of SCC or GEJ (esophagogastric junction) cancer after preoperative chemoradiation and complete resection have access to adjuvant immunotherapy (independent of PD-L1 (programmed cell death protein 1) status, nivolumab, CHECKMATE 577). For metastatic SCC in the first-line, nivolumab combined with chemotherapy or with ipilimumab (TPS (tumor proportion score) ≥1 %, SCC, CHECKMATE 648) are approved, as well as second-line nivolumab alone regardless of PD-L1 status (ATTRACTION 03). For both, locally advanced or metastatic SCC and EGC, chemotherapy with pembrolizumab is available for patients with CPS (combined positive score) ≥10 (KEYNOTE 590) and for adenocarcinoma with nivolumab (CPS ≥5, CHECKMATE 649). Recent added approvals are chemotherapy with pembrolizumab in CPS ≥1 patients (KEYNOTE 859) and the addition of trastuzumab for personalized therapy in HER-2 positive/CPS ≥1 gastric and GEJ patients (KEYNOTE 811).

最近批准的免疫检查点抑制剂(ICIs)丰富了几乎所有晚期/转移性鳞状细胞癌(SCC)和食管胃腺癌(EGC)患者的治疗前景。在治疗预期治疗中,术前放化疗和完全切除后无SCC或GEJ(食管胃结)癌病理残留病变的患者可以接受辅助免疫治疗(独立于PD-L1(程序性细胞死亡蛋白1)状态,nivolumab, CHECKMATE 577)。对于一线转移性SCC,纳武单抗联合化疗或伊匹单抗(TPS(肿瘤比例评分)≥1 %,SCC, CHECKMATE 648)被批准,以及二线单独纳武单抗,无论PD-L1状态如何(ATTRACTION 03)。对于局部晚期或转移性SCC和EGC, pembrolizumab化疗可用于CPS(联合阳性评分)≥10 (KEYNOTE 590)和纳沃单抗(CPS≥5,CHECKMATE 649)的腺癌患者。最近增加的批准是pembrolizumab用于CPS≥1患者的化疗(KEYNOTE 859)和曲妥珠单抗用于HER-2阳性/CPS≥1的胃和GEJ患者的个性化治疗(KEYNOTE 811)。
{"title":"Immunotherapy as a new perspective for the therapy of esophageal cancer.","authors":"Yvonne Huber, Markus Moehler, Anica Högner","doi":"10.1515/iss-2023-0023","DOIUrl":"10.1515/iss-2023-0023","url":null,"abstract":"<p><p>The therapeutic landscape in nearly every therapeutic line in advanced/metastatic patients with squamous cell carcinoma (SCC) and esophagogastric adenocarcinoma (EGC) is enriched by recent approvals of immune checkpoint inhibitors (ICIs). In curative intended therapy, patients without pathological residual disease of SCC or GEJ (esophagogastric junction) cancer after preoperative chemoradiation and complete resection have access to adjuvant immunotherapy (independent of PD-L1 (programmed cell death protein 1) status, nivolumab, CHECKMATE 577). For metastatic SCC in the first-line, nivolumab combined with chemotherapy or with ipilimumab (TPS (tumor proportion score) ≥1 %, SCC, CHECKMATE 648) are approved, as well as second-line nivolumab alone regardless of PD-L1 status (ATTRACTION 03). For both, locally advanced or metastatic SCC and EGC, chemotherapy with pembrolizumab is available for patients with CPS (combined positive score) ≥10 (KEYNOTE 590) and for adenocarcinoma with nivolumab (CPS ≥5, CHECKMATE 649). Recent added approvals are chemotherapy with pembrolizumab in CPS ≥1 patients (KEYNOTE 859) and the addition of trastuzumab for personalized therapy in HER-2 positive/CPS ≥1 gastric and GEJ patients (KEYNOTE 811).</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 1","pages":"37-41"},"PeriodicalIF":1.7,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934939/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A narrative review of present knowledge and digital approaches in orthognathic surgery. 叙述回顾目前的知识和数字方法在正颌手术。
IF 1.7 Q2 SURGERY Pub Date : 2024-09-06 eCollection Date: 2024-12-01 DOI: 10.1515/iss-2024-0018
Constanze Friedrich, Constantin Graw, Juliane Kröplin

Introduction: Anomalies of jaw position and shape affect approximately 10 % of the population. They can have a significant impact on quality of life, which is why the continuous improvement of therapeutic approaches is a key concern in oral and maxillofacial surgery. The aim of this narrative review article is to examine the development of orthognathic surgery in the context of traditional and innovative methods.

Content: A Pubmed-based selective literature search was performed considering literature predominantly from 2022 to 2023. Search terms were "orthognathic surgery" in combination with "virtual surgical planning" and "3D printing".

Summary: Depending on the extent of the existing anomalies, there are purely orthodontic or combined orthodontic-surgical treatment approaches. Technological innovations in particular are changing both the therapeutic approach and the planning of surgical treatment to an almost completely digital workflow. This change can lead to greater precision in treatment and more efficient planning, resulting in reduced costs and an overall improvement in clinical outcomes, including patient satisfaction.

Outlook: This study presents an overview of the field of orthognathic surgery and discusses developments and challenges for the future. With traditional approaches being time-consuming and prone to error digital technologies like VSP, AI and PSIs improve accuracy and efficiency, though challenges persist.

简介约有 10% 的人口受到下颌位置和形状异常的影响。它们会对生活质量产生重大影响,因此不断改进治疗方法是口腔颌面外科关注的重点。这篇叙述性综述文章旨在从传统和创新方法的角度探讨正颌外科的发展:基于Pubmed的选择性文献检索主要考虑了2022年至2023年的文献。搜索关键词为 "正颌外科手术 "以及 "虚拟手术规划 "和 "3D打印"。摘要:根据现有异常的程度,有纯正畸或正畸与外科手术相结合的治疗方法。特别是技术创新正在改变治疗方法和手术治疗计划,使其几乎完全数字化。这种变化可以提高治疗的精确度和规划的效率,从而降低成本,全面改善临床效果,包括提高患者满意度:本研究概述了正颌外科领域,并讨论了未来的发展和挑战。由于传统方法耗时且容易出错,VSP、人工智能和 PSI 等数字技术提高了准确性和效率,但挑战依然存在。
{"title":"A narrative review of present knowledge and digital approaches in orthognathic surgery.","authors":"Constanze Friedrich, Constantin Graw, Juliane Kröplin","doi":"10.1515/iss-2024-0018","DOIUrl":"10.1515/iss-2024-0018","url":null,"abstract":"<p><strong>Introduction: </strong>Anomalies of jaw position and shape affect approximately 10 % of the population. They can have a significant impact on quality of life, which is why the continuous improvement of therapeutic approaches is a key concern in oral and maxillofacial surgery. The aim of this narrative review article is to examine the development of orthognathic surgery in the context of traditional and innovative methods.</p><p><strong>Content: </strong>A Pubmed-based selective literature search was performed considering literature predominantly from 2022 to 2023. Search terms were \"orthognathic surgery\" in combination with \"virtual surgical planning\" and \"3D printing\".</p><p><strong>Summary: </strong>Depending on the extent of the existing anomalies, there are purely orthodontic or combined orthodontic-surgical treatment approaches. Technological innovations in particular are changing both the therapeutic approach and the planning of surgical treatment to an almost completely digital workflow. This change can lead to greater precision in treatment and more efficient planning, resulting in reduced costs and an overall improvement in clinical outcomes, including patient satisfaction.</p><p><strong>Outlook: </strong>This study presents an overview of the field of orthognathic surgery and discusses developments and challenges for the future. With traditional approaches being time-consuming and prone to error digital technologies like VSP, AI and PSIs improve accuracy and efficiency, though challenges persist.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"9 4","pages":"175-179"},"PeriodicalIF":1.7,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conventional partial pancreatoduodenectomy versus an uncinate first, extended partial pancreatoduodenectomy approach for the resection of pancreatic head cancer: the randomized, controlled PancER trial. 传统部分胰十二指肠切除术与先切除胰头癌的扩展部分胰十二指肠切除术:随机对照PancER试验
IF 1.2 Q2 SURGERY Pub Date : 2024-08-26 eCollection Date: 2025-09-01 DOI: 10.1515/iss-2024-0014
Patrick Heger, Markus K Diener, Manuel Feißt, Matthias M Gaida, Christina Klose, Phillip Knebel, Rosa Klotz, Colette Dörr-Harim, André L Mihaljevic

Objectives: After pancreatoduodenectomy (PD) due to pancreatic cancer, recurrence is frequent in almost half of the patients. The rate of R0 resections is associated with the probability of local recurrence and overall survival. A potential intervention to improve the rate of R0 resections is a more radical resection along the superior mesenteric artery (SMA); however, randomized data of such an approach are lacking. Therefore, we conducted the randomized, controlled PancER trial to evaluate the effect of an extended PD compared with conventional PD.

Methods: Patients were randomized to either an extended PD consisting of a modified Kocher maneuver with partial resection of the prerenal fascia, an uncinate process first approach with systematic mesopancreatic dissection along the SMA equivalent to level III dissection according to Inoue, or conventional PD. The primary endpoint, rate of R0 resections, and other perioperative outcomes were compared.

Results: A total of 50 patients were randomly assigned to extended PD (n=24) or conventional PD (n=26). R0 resections were 10 % more frequent in the extended PD group than in the conventional group (75.0 vs. 64.7 %), which was not statistically significant (p=0.59). Patients self-reported more diarrhea symptoms following extended PD after 30 days (p<0.01). Other perioperative outcomes as well as long-term outcomes were comparable between the two groups.

Conclusion: The PancER trial shows that extended PD with more radical resection along the SMA can be performed with comparable perioperative outcomes to conventional PD. Although the intervention improved the R0 resection rate by 10 %, this increase was below expectation. Therefore, an even more radical PD resection technique involving not only the SMA but also the celiac and hepatic artery (TRIANGLE operation) was developed at Heidelberg University. The TRIANGLE operation is currently being evaluated in a randomized controlled multicenter trial. The results of the PancER trial served as pilot data for this subsequent study.

目的:胰腺癌行胰十二指肠切除术(PD)后,近半数患者复发。R0切除率与局部复发率和总生存率相关。提高R0切除率的潜在干预措施是沿肠系膜上动脉(SMA)进行更根治性切除;然而,缺乏这种方法的随机数据。因此,我们进行了随机对照PancER试验,以评估延长PD与常规PD的效果。方法:患者被随机分为两组,一组是扩展PD,包括改良的Kocher手法和部分切除肾筋膜,另一组是扣突先入路,沿着SMA进行系统性胰腺间系剥离,相当于Inoue的III级剥离,另一组是常规PD。比较主要终点、R0切除率和其他围手术期结果。结果:共有50例患者被随机分配到延长PD组(n=24)或常规PD组(n=26)。扩展PD组的R0切除频率比常规组高10 % (75.0 vs 64.7 %),差异无统计学意义(p=0.59)。结论:PancER试验表明,延长PD并沿SMA进行更根治性切除的围手术期预后与常规PD相当。虽然干预使R0切除率提高了10 %,但这一增幅低于预期。因此,海德堡大学开发了一种更彻底的PD切除技术,不仅包括SMA,还包括腹腔和肝动脉(TRIANGLE手术)。TRIANGLE手术目前正在一项随机对照多中心试验中进行评估。PancER试验的结果作为后续研究的先导数据。
{"title":"Conventional partial pancreatoduodenectomy versus an uncinate first, extended partial pancreatoduodenectomy approach for the resection of pancreatic head cancer: the randomized, controlled PancER trial.","authors":"Patrick Heger, Markus K Diener, Manuel Feißt, Matthias M Gaida, Christina Klose, Phillip Knebel, Rosa Klotz, Colette Dörr-Harim, André L Mihaljevic","doi":"10.1515/iss-2024-0014","DOIUrl":"10.1515/iss-2024-0014","url":null,"abstract":"<p><strong>Objectives: </strong>After pancreatoduodenectomy (PD) due to pancreatic cancer, recurrence is frequent in almost half of the patients. The rate of R0 resections is associated with the probability of local recurrence and overall survival. A potential intervention to improve the rate of R0 resections is a more radical resection along the superior mesenteric artery (SMA); however, randomized data of such an approach are lacking. Therefore, we conducted the randomized, controlled PancER trial to evaluate the effect of an extended PD compared with conventional PD.</p><p><strong>Methods: </strong>Patients were randomized to either an extended PD consisting of a modified Kocher maneuver with partial resection of the prerenal fascia, an uncinate process first approach with systematic mesopancreatic dissection along the SMA equivalent to level III dissection according to Inoue, or conventional PD. The primary endpoint, rate of R0 resections, and other perioperative outcomes were compared.</p><p><strong>Results: </strong>A total of 50 patients were randomly assigned to extended PD (n=24) or conventional PD (n=26). R0 resections were 10 % more frequent in the extended PD group than in the conventional group (75.0 vs. 64.7 %), which was not statistically significant (p=0.59). Patients self-reported more diarrhea symptoms following extended PD after 30 days (p<0.01). Other perioperative outcomes as well as long-term outcomes were comparable between the two groups.</p><p><strong>Conclusion: </strong>The PancER trial shows that extended PD with more radical resection along the SMA can be performed with comparable perioperative outcomes to conventional PD. Although the intervention improved the R0 resection rate by 10 %, this increase was below expectation. Therefore, an even more radical PD resection technique involving not only the SMA but also the celiac and hepatic artery (TRIANGLE operation) was developed at Heidelberg University. The TRIANGLE operation is currently being evaluated in a randomized controlled multicenter trial. The results of the PancER trial served as pilot data for this subsequent study.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 3","pages":"109-119"},"PeriodicalIF":1.2,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12552034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update burn surgery: overview of current multidisciplinary treatment concepts. 更新烧伤手术:当前多学科治疗概念概述。
IF 1.7 Q2 SURGERY Pub Date : 2024-08-23 eCollection Date: 2024-12-01 DOI: 10.1515/iss-2024-0020
Frederik Schlottmann, Lisa Lorbeer

The treatment of severe burn injuries is an essential part of plastic-reconstructive surgery. Severe burned patients are treated in burn centers, which have highly specialized technical and personnel equipment. In addition to clear recommendations for prehospital management, intensive care therapy is usually required for extensive burn wounds. Shock therapy in burns primarily involves balanced fluid resuscitation according to hemodynamic monitoring, vasopressor support, pain management, temperature regulation, oxygen therapy, and comprehensive supportive care to stabilize the patient's condition. Surgical treatment is still based on wound debridement and the gold standard of autologous split-thickness skin grafting. Besides skin transplantation, surgical management of burns may also involve the application of various topical therapies to promote wound healing, reduce pain, and prevent infection. These therapies may include antimicrobial dressings, skin substitutes, growth factors, or specialized wound care products. Once the acute treatment has been completed, multidisciplinary rehabilitation treatment takes place, which begins in the acute hospital and continues in the outpatient and inpatient rehabilitation areas. Surgical treatment of the secondary complications of burns and scars is also an important component of burn care. Comprehensive knowledge of the various components and players involved in the care of severely burned patients is, therefore, required in order to achieve the best possible outcome for the patient.

治疗严重烧伤是整形修复手术的重要组成部分。重度烧伤患者在烧伤中心接受治疗,这些中心拥有高度专业化的技术和人员设备。除了明确的院前处理建议外,大面积烧伤通常还需要重症监护治疗。烧伤休克治疗主要包括根据血流动力学监测结果进行均衡液体复苏、血管加压支持、疼痛控制、体温调节、氧疗和综合支持护理,以稳定患者病情。手术治疗仍以伤口清创和自体分层厚皮移植的金标准为基础。除皮肤移植外,烧伤的外科治疗还可能包括应用各种局部疗法来促进伤口愈合、减轻疼痛和预防感染。这些疗法可能包括抗菌敷料、皮肤替代品、生长因子或专门的伤口护理产品。急性治疗结束后,多学科康复治疗将在急诊医院开始,并在门诊和住院康复区继续进行。烧伤和疤痕继发并发症的外科治疗也是烧伤护理的重要组成部分。因此,需要全面了解严重烧伤病人护理所涉及的各个环节和参与者,以便为病人实现最佳治疗效果。
{"title":"Update burn surgery: overview of current multidisciplinary treatment concepts.","authors":"Frederik Schlottmann, Lisa Lorbeer","doi":"10.1515/iss-2024-0020","DOIUrl":"10.1515/iss-2024-0020","url":null,"abstract":"<p><p>The treatment of severe burn injuries is an essential part of plastic-reconstructive surgery. Severe burned patients are treated in burn centers, which have highly specialized technical and personnel equipment. In addition to clear recommendations for prehospital management, intensive care therapy is usually required for extensive burn wounds. Shock therapy in burns primarily involves balanced fluid resuscitation according to hemodynamic monitoring, vasopressor support, pain management, temperature regulation, oxygen therapy, and comprehensive supportive care to stabilize the patient's condition. Surgical treatment is still based on wound debridement and the gold standard of autologous split-thickness skin grafting. Besides skin transplantation, surgical management of burns may also involve the application of various topical therapies to promote wound healing, reduce pain, and prevent infection. These therapies may include antimicrobial dressings, skin substitutes, growth factors, or specialized wound care products. Once the acute treatment has been completed, multidisciplinary rehabilitation treatment takes place, which begins in the acute hospital and continues in the outpatient and inpatient rehabilitation areas. Surgical treatment of the secondary complications of burns and scars is also an important component of burn care. Comprehensive knowledge of the various components and players involved in the care of severely burned patients is, therefore, required in order to achieve the best possible outcome for the patient.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"9 4","pages":"181-190"},"PeriodicalIF":1.7,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638824/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early enteral nutrition (EEN) following intestinal anastomosis in pediatric patients - what's new? 小儿肠吻合术后早期肠内营养(EEN) -有什么新进展?
IF 1.7 Q2 SURGERY Pub Date : 2024-08-20 eCollection Date: 2024-12-01 DOI: 10.1515/iss-2024-0017
Sabine Drossard, Louisa Schuffert

Introduction: Abdominal surgery in children may disrupt normal gut function, necessitating prolonged fasting, which can lead to complications such as dehydration and nutritional deficits. Early enteral nutrition (EEN) after surgical procedures can enhance wound healing, prevent malnutrition, and expedite recovery. Although concerns exist regarding the risk of complications associated with EEN, current evidence suggests that it is not linked to increased perioperative complications.

Content: This scoping review provides an overview of the role of EEN in pediatric abdominal surgery, exploring its benefits and risks within the context of recent literature from 2021 to 2024. A systematic literature search was conducted using the PubMed database in April 2024 and the identified studies were compared. The search revealed 586 results, wherefrom eight studies (three systematic reviews and five clinical studies) fulfilled the inclusion criteria. Five studies were added since 2021. Overall, EEN may reduce the length of hospital stay, time to full oral intake, and return of bowel function. It does not seem to increase the rate of anastomotic leakage. EEN is associated with lower rates of surgical site infections and wound dehiscence as well as fewer septic complications. One study showed an increase in nausea/vomiting and abdominal distension in the EEN group, which did not lead to further complications.

Summary and outlook: Current evidence suggests that EEN after abdominal surgery in pediatric patients is not associated with a higher rate of complications. In fact, EEN seems to be beneficial and lead to improved patient outcomes and shorter hospital stays. Emphasis on patient and parent comfort, individualized feeding initiation based on clinical factors, and standardized postoperative feeding protocols are recommended to optimize outcomes in pediatric abdominal surgery.

儿童腹部手术可能会破坏正常的肠道功能,需要长时间禁食,这可能导致脱水和营养缺乏等并发症。外科手术后早期肠内营养(EEN)可以促进伤口愈合,防止营养不良,并加快恢复。尽管存在对EEN相关并发症风险的担忧,但目前的证据表明,它与围手术期并发症的增加无关。内容:本综述概述了EEN在小儿腹部手术中的作用,并在2021年至2024年的最新文献背景下探讨了其益处和风险。于2024年4月使用PubMed数据库进行了系统的文献检索,并对确定的研究进行了比较。检索结果为586项,其中8项研究(3项系统综述和5项临床研究)符合纳入标准。自2021年以来增加了五项研究。总的来说,EEN可以缩短住院时间、达到完全口服的时间和肠道功能的恢复。它似乎并没有增加吻合口瘘的发生率。EEN与较低的手术部位感染和伤口裂开率以及较少的脓毒性并发症有关。一项研究显示,EEN组恶心/呕吐和腹胀增加,但没有导致进一步的并发症。总结与展望:目前的证据表明,儿科患者腹部手术后的EEN与并发症的高发生率无关。事实上,EEN似乎是有益的,可以改善患者的预后,缩短住院时间。建议强调患者和家长的舒适,根据临床因素进行个性化喂养,以及标准化的术后喂养方案,以优化儿科腹部手术的结果。
{"title":"Early enteral nutrition (EEN) following intestinal anastomosis in pediatric patients - what's new?","authors":"Sabine Drossard, Louisa Schuffert","doi":"10.1515/iss-2024-0017","DOIUrl":"10.1515/iss-2024-0017","url":null,"abstract":"<p><strong>Introduction: </strong>Abdominal surgery in children may disrupt normal gut function, necessitating prolonged fasting, which can lead to complications such as dehydration and nutritional deficits. Early enteral nutrition (EEN) after surgical procedures can enhance wound healing, prevent malnutrition, and expedite recovery. Although concerns exist regarding the risk of complications associated with EEN, current evidence suggests that it is not linked to increased perioperative complications.</p><p><strong>Content: </strong>This scoping review provides an overview of the role of EEN in pediatric abdominal surgery, exploring its benefits and risks within the context of recent literature from 2021 to 2024. A systematic literature search was conducted using the PubMed database in April 2024 and the identified studies were compared. The search revealed 586 results, wherefrom eight studies (three systematic reviews and five clinical studies) fulfilled the inclusion criteria. Five studies were added since 2021. Overall, EEN may reduce the length of hospital stay, time to full oral intake, and return of bowel function. It does not seem to increase the rate of anastomotic leakage. EEN is associated with lower rates of surgical site infections and wound dehiscence as well as fewer septic complications. One study showed an increase in nausea/vomiting and abdominal distension in the EEN group, which did not lead to further complications.</p><p><strong>Summary and outlook: </strong>Current evidence suggests that EEN after abdominal surgery in pediatric patients is not associated with a higher rate of complications. In fact, EEN seems to be beneficial and lead to improved patient outcomes and shorter hospital stays. Emphasis on patient and parent comfort, individualized feeding initiation based on clinical factors, and standardized postoperative feeding protocols are recommended to optimize outcomes in pediatric abdominal surgery.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"9 4","pages":"167-173"},"PeriodicalIF":1.7,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of subepithelial esophageal tumors. 食管上皮下肿瘤的治疗。
IF 1.7 Q2 SURGERY Pub Date : 2024-08-20 eCollection Date: 2025-03-01 DOI: 10.1515/iss-2023-0011
Marcel A Schneider, Diana Vetter, Christian A Gutschow

Subepithelial esophageal tumors (SET) are normally benign intramural esophageal lesions of mesenchymal origin. Although rare, the incidence of SET has increased in recent decades due to the more widespread use of endoscopy and diagnostic imaging. The current review aims to provide an overview of the histopathologic spectrum and the most frequent entities including leiomyoma and gastrointestinal stromal tumor (GIST), diagnostic workup, and multidisciplinary treatment options. Staging for SET should include endoscopy, endoscopic ultrasonography (EUS), and tissue sampling. Current consensus guidelines recommend that SET suggestive of gastrointestinal stromal tumor (GIST) larger than 20 mm or lesions with high-risk stigmata should undergo tissue sampling. Most SET have an excellent long-term outcome, but malignancy may be present in certain subtypes. Asymptomatic SET without high-risk stigmata discovered incidentally usually do not require specific treatment. However, depending on the size and location of the lesion symptoms may occur. Therapeutic interventions range from endoscopic interventional resections to major surgical procedures. Enucleation via minimally invasive or robotic-assisted access remains the standard of care for most SET sub-entities.

食管上皮下肿瘤(SET)通常是良性食管壁内的间质病变。虽然罕见,但近几十年来,由于内窥镜检查和诊断成像的广泛应用,SET的发病率有所增加。本综述旨在提供组织病理学谱和最常见的实体,包括平滑肌瘤和胃肠道间质瘤(GIST),诊断检查和多学科治疗方案的概述。SET的分期应包括内窥镜检查、内窥镜超声检查和组织取样。目前的共识指南建议,当胃肠道间质瘤(GIST)大于20 mm或病变伴有高危红斑时,应进行组织采样。大多数SET有良好的长期预后,但某些亚型可能存在恶性肿瘤。偶然发现的无症状且无高危柱头的SET通常不需要特殊治疗。然而,根据病变的大小和位置,可能会出现症状。治疗干预措施范围从内窥镜介入切除到主要外科手术。通过微创或机器人辅助摘除眼球仍然是大多数SET亚实体的标准治疗方法。
{"title":"Management of subepithelial esophageal tumors.","authors":"Marcel A Schneider, Diana Vetter, Christian A Gutschow","doi":"10.1515/iss-2023-0011","DOIUrl":"10.1515/iss-2023-0011","url":null,"abstract":"<p><p>Subepithelial esophageal tumors (SET) are normally benign intramural esophageal lesions of mesenchymal origin. Although rare, the incidence of SET has increased in recent decades due to the more widespread use of endoscopy and diagnostic imaging. The current review aims to provide an overview of the histopathologic spectrum and the most frequent entities including leiomyoma and gastrointestinal stromal tumor (GIST), diagnostic workup, and multidisciplinary treatment options. Staging for SET should include endoscopy, endoscopic ultrasonography (EUS), and tissue sampling. Current consensus guidelines recommend that SET suggestive of gastrointestinal stromal tumor (GIST) larger than 20 mm or lesions with high-risk stigmata should undergo tissue sampling. Most SET have an excellent long-term outcome, but malignancy may be present in certain subtypes. Asymptomatic SET without high-risk stigmata discovered incidentally usually do not require specific treatment. However, depending on the size and location of the lesion symptoms may occur. Therapeutic interventions range from endoscopic interventional resections to major surgical procedures. Enucleation via minimally invasive or robotic-assisted access remains the standard of care for most SET sub-entities.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 1","pages":"21-30"},"PeriodicalIF":1.7,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning for automated boundary detection and segmentation in organ donation photography. 器官捐献摄影中自动边界检测与分割的深度学习。
IF 1.2 Q2 SURGERY Pub Date : 2024-08-20 eCollection Date: 2025-09-01 DOI: 10.1515/iss-2024-0022
Georgios Kourounis, Ali Ahmed Elmahmudi, Brian Thomson, Robin Nandi, Samuel J Tingle, Emily K Glover, Emily Thompson, Balaji Mahendran, Chloe Connelly, Beth Gibson, Lucy Bates, Neil S Sheerin, James Hunter, Hassan Ugail, Colin Wilson

Objectives: Medical photography is ubiquitous and plays an increasingly important role in the fields of medicine and surgery. Any assessment of these photographs by computer vision algorithms requires first that the area of interest can accurately be delineated from the background. We aimed to develop deep learning segmentation models for kidney and liver organ donation photographs where accurate automated segmentation has not yet been described.

Methods: Two novel deep learning models (Detectron2 and YoloV8) were developed using transfer learning and compared against existing tools for background removal (macBGRemoval, remBGisnet, remBGu2net). Anonymised photograph datasets comprised training/internal validation sets (821 kidney and 400 liver images) and external validation sets (203 kidney and 208 liver images). Each image had two segmentation labels: whole organ and clear view (parenchyma only). Intersection over Union (IoU) was the primary outcome, as the recommended metric for assessing segmentation performance.

Results: In whole kidney segmentation, Detectron2 and YoloV8 outperformed other models with internal validation IoU of 0.93 and 0.94, and external validation IoU of 0.92 and 0.94, respectively. Other methods - macBGRemoval, remBGisnet and remBGu2net - scored lower, with highest internal validation IoU at 0.54 and external validation at 0.59. Similar results were observed in liver segmentation, where Detectron2 and YoloV8 both showed internal validation IoU of 0.97 and external validation of 0.92 and 0.91, respectively. The other models showed a maximum internal validation and external validation IoU of 0.89 and 0.59 respectively. All image segmentation tasks with Detectron2 and YoloV8 completed within 0.13-1.5 s per image.

Conclusions: Accurate, rapid and automated image segmentation in the context of surgical photography is possible with open-source deep-learning software. These outperform existing methods and could impact the field of surgery, enabling similar advancements seen in other areas of medical computer vision.

目的:医学摄影无处不在,在医学和外科领域发挥着越来越重要的作用。计算机视觉算法对这些照片的任何评估都要求首先可以从背景中准确地描绘出感兴趣的区域。我们的目标是开发肾脏和肝脏器官捐赠照片的深度学习分割模型,其中尚未描述准确的自动分割。方法:利用迁移学习开发了两种新的深度学习模型(Detectron2和YoloV8),并与现有的背景去除工具(macBGRemoval, remBGisnet, remBGu2net)进行了比较。匿名照片数据集包括训练/内部验证集(821张肾脏和400张肝脏图像)和外部验证集(203张肾脏和208张肝脏图像)。每张图像有两个分割标签:整个器官和清晰视图(仅限实质)。交叉联(IoU)是主要结果,作为评估分割性能的推荐指标。结果:在全肾分割中,Detectron2和YoloV8的内部验证IoU分别为0.93和0.94,外部验证IoU分别为0.92和0.94,优于其他模型。其他方法——macBGRemoval、remBGisnet和remBGu2net——得分较低,内部验证IoU最高为0.54,外部验证IoU最高为0.59。在肝脏分割中也有类似的结果,Detectron2和YoloV8的内部验证IoU分别为0.97,外部验证IoU分别为0.92和0.91。其他模型的最大内部验证IoU和外部验证IoU分别为0.89和0.59。Detectron2和YoloV8在每张图像0.13-1.5 s内完成所有图像分割任务。结论:开放源代码的深度学习软件可以实现外科摄影中准确、快速和自动化的图像分割。这些方法优于现有的方法,并可能影响手术领域,从而在医疗计算机视觉的其他领域实现类似的进步。
{"title":"Deep learning for automated boundary detection and segmentation in organ donation photography.","authors":"Georgios Kourounis, Ali Ahmed Elmahmudi, Brian Thomson, Robin Nandi, Samuel J Tingle, Emily K Glover, Emily Thompson, Balaji Mahendran, Chloe Connelly, Beth Gibson, Lucy Bates, Neil S Sheerin, James Hunter, Hassan Ugail, Colin Wilson","doi":"10.1515/iss-2024-0022","DOIUrl":"10.1515/iss-2024-0022","url":null,"abstract":"<p><strong>Objectives: </strong>Medical photography is ubiquitous and plays an increasingly important role in the fields of medicine and surgery. Any assessment of these photographs by computer vision algorithms requires first that the area of interest can accurately be delineated from the background. We aimed to develop deep learning segmentation models for kidney and liver organ donation photographs where accurate automated segmentation has not yet been described.</p><p><strong>Methods: </strong>Two novel deep learning models (Detectron2 and YoloV8) were developed using transfer learning and compared against existing tools for background removal (macBGRemoval, remBGisnet, remBGu2net). Anonymised photograph datasets comprised training/internal validation sets (821 kidney and 400 liver images) and external validation sets (203 kidney and 208 liver images). Each image had two segmentation labels: whole organ and clear view (parenchyma only). Intersection over Union (IoU) was the primary outcome, as the recommended metric for assessing segmentation performance.</p><p><strong>Results: </strong>In whole kidney segmentation, Detectron2 and YoloV8 outperformed other models with internal validation IoU of 0.93 and 0.94, and external validation IoU of 0.92 and 0.94, respectively. Other methods - macBGRemoval, remBGisnet and remBGu2net - scored lower, with highest internal validation IoU at 0.54 and external validation at 0.59. Similar results were observed in liver segmentation, where Detectron2 and YoloV8 both showed internal validation IoU of 0.97 and external validation of 0.92 and 0.91, respectively. The other models showed a maximum internal validation and external validation IoU of 0.89 and 0.59 respectively. All image segmentation tasks with Detectron2 and YoloV8 completed within 0.13-1.5 s per image.</p><p><strong>Conclusions: </strong>Accurate, rapid and automated image segmentation in the context of surgical photography is possible with open-source deep-learning software. These outperform existing methods and could impact the field of surgery, enabling similar advancements seen in other areas of medical computer vision.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":" ","pages":"131-141"},"PeriodicalIF":1.2,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7617812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oligometastatic disease - a renaissance for surgery? 少转移性疾病——手术的复兴?
IF 1.7 Q2 SURGERY Pub Date : 2024-08-02 eCollection Date: 2025-03-01 DOI: 10.1515/iss-2023-0044
Thorsten Goetze, Mickael Chevallay, Michel Dosch, Jordan Marcelis, Salah-Eddin Al-Batran, Stefan Paul Mönig

Half of the patients with esophageal cancer, cancer of the gastro-esophageal junction and gastric cancer present metastasis at the time of diagnosis. In addition, even patients originally thought to be free of metastasis will present metachronous metastasis in the course of the disease. These patients are considered incurable and current standard of care for metastatic esophageal, gastro-esophageal junction and gastric cancers is a systemic therapy without curative intention. However, patients presenting only a low metastatic load are now defined as oligometastatic disease and should benefit from an aggressive, multimodal therapy. We present here a review of recent publications investigating multimodal therapies for oligometastatic disease and showing that a systemic therapy combined with a resection of the primary tumor together with metastasis is associated with a better prognosis than a systemic therapy alone. We also give a precise focus on esophageal squamous cell carcinomas and adenocarcinomas of the gastro-esophageal junction and of the stomach. Interestingly, patients with oligometastatic cancer of the esophago-gastric junction can even be treated in curative intention with such a multimodal therapy as we present here in a short case report. In conclusion, new therapeutic strategies including multimodal approaches for oligometastatic disease have shown promising results in the last years and ongoing randomized prospective trials will provide us the evidence to include them in future European guidelines.

半数食管癌、胃-食管交界处癌和胃癌患者在诊断时出现转移。此外,即使原本认为无转移的患者在病程中也会出现异时性转移。这些患者被认为是无法治愈的,目前转移性食管癌、胃-食管癌和胃癌的治疗标准是一种没有治愈意图的全身治疗。然而,只有低转移负荷的患者现在被定义为低转移性疾病,应该从积极的多模式治疗中获益。在此,我们对最近发表的研究少转移性疾病的多模式治疗的文献进行了回顾,并表明全身治疗联合原发肿瘤切除和转移比单独全身治疗有更好的预后。我们也给出了一个精确的重点食管鳞状细胞癌和腺癌的胃-食管交界处和胃。有趣的是,食管-胃交界处的少转移癌患者甚至可以用这种多模式治疗来治疗,正如我们在这里的一个简短的病例报告中所述。总之,包括多模式治疗方法在内的新治疗策略在过去几年中已经显示出有希望的结果,正在进行的随机前瞻性试验将为我们提供证据,将其纳入未来的欧洲指南。
{"title":"Oligometastatic disease - a renaissance for surgery?","authors":"Thorsten Goetze, Mickael Chevallay, Michel Dosch, Jordan Marcelis, Salah-Eddin Al-Batran, Stefan Paul Mönig","doi":"10.1515/iss-2023-0044","DOIUrl":"10.1515/iss-2023-0044","url":null,"abstract":"<p><p>Half of the patients with esophageal cancer, cancer of the gastro-esophageal junction and gastric cancer present metastasis at the time of diagnosis. In addition, even patients originally thought to be free of metastasis will present metachronous metastasis in the course of the disease. These patients are considered incurable and current standard of care for metastatic esophageal, gastro-esophageal junction and gastric cancers is a systemic therapy without curative intention. However, patients presenting only a low metastatic load are now defined as oligometastatic disease and should benefit from an aggressive, multimodal therapy. We present here a review of recent publications investigating multimodal therapies for oligometastatic disease and showing that a systemic therapy combined with a resection of the primary tumor together with metastasis is associated with a better prognosis than a systemic therapy alone. We also give a precise focus on esophageal squamous cell carcinomas and adenocarcinomas of the gastro-esophageal junction and of the stomach. Interestingly, patients with oligometastatic cancer of the esophago-gastric junction can even be treated in curative intention with such a multimodal therapy as we present here in a short case report. In conclusion, new therapeutic strategies including multimodal approaches for oligometastatic disease have shown promising results in the last years and ongoing randomized prospective trials will provide us the evidence to include them in future European guidelines.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 1","pages":"51-59"},"PeriodicalIF":1.7,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934942/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of outcome (QoO) in oral cancer patients: prospective perioperative analysis of patients' resilience and satisfaction during inpatient stay at a University Medical Centre in Germany. 口腔癌患者的预后质量(QoO):德国一所大学医学中心住院期间患者恢复力和满意度的前瞻性围手术期分析
IF 1.2 Q2 SURGERY Pub Date : 2024-08-02 eCollection Date: 2025-09-01 DOI: 10.1515/iss-2024-0026
Juliane Kröplin, Jil-Charlot Reppenhagen, Anke Hirsemann, Jan Liese, Bernhard Frerich

Objectives: Quality assurance strategies for head and neck surgery can improve patient outcomes. This study aims a perioperative analysis of indicators in the quality of outcome in oral cancer patients with special focus on patient`s resilience and satisfaction before and after surgery.

Methods: Patients with oral cancer (OCP) and indication for surgical resection were included in a prospective study. General and disease-related data as well as parameters of patient-specific resilience (RS-11 questionnaire) and physical strength (ECOG-Score) were collected. Importance and satisfaction using the nine items family/friends, sports activities/physiotherapy, participation in culture, professional perspectives, sexuality, enjoyable food, external appearance, social recognition and independence were analysed. The data collection took place pre- and postoperatively (mean: 10th postop day) during the inpatient stay.

Results: Twenty-eight patients with oral cancer (OCP) were analysed (male: n=23, female n=5). The rate of R0 resections was 92.6 %. The average length of stay was 21 days. n=16 of all patients was tracheotomised postop (preop: n=0). n=0 patients confirmed psycho(onco)logical support preop (postop: n=19). Sports activities/physiotherapy was provided to n=3 patients preop (postop: n=21). The mean pre and postop pain perception was 3/10. The RS-11 score decreased significantly postoperatively (p=0.01). A significant loss of satisfaction was seen in the areas of enjoyable food (p<0.001), social recognition (p=0.01), external appearance (p=0.01) and independence (p<0.001).

Conclusions: Supportive therapy measures to promote mental and physical fitness of oral cancer patients are part of inpatient care at our clinic. However, there is no standardised monitoring of these therapies. Digitally supported and standardised programmes to increase mental and physical fitness in both prehospital and inpatient care might lead to an improvement in the quality of outcome despite shortage of resources in terms of time, costs and personnel. A minimally invasive approach to tracheal cannula management and lymph node management in the treatment of OCP can help to reduce the length of stay in the intensive care unit.

目的:头颈部手术的质量保证策略可以改善患者的预后。本研究旨在对口腔癌患者围手术期预后质量指标进行分析,重点关注患者术前和术后的适应能力和满意度。方法:前瞻性研究包括口腔癌(OCP)患者和手术切除指征。收集一般和疾病相关数据,以及患者特异性恢复力(RS-11问卷)和体力(ECOG-Score)参数。对家庭/朋友、体育活动/物理治疗、文化参与、专业观点、性、愉快的食物、外表、社会认可和独立性这九个项目的重要性和满意度进行了分析。数据收集在住院期间进行术前和术后(平均:术后第10天)。结果:共分析了28例口腔癌(OCP)患者,其中男性23例,女性5例。R0切除率为92.6 %。平均住院时间为21天。16例患者术后行气管切开术(术前N =0)。术前确认有心理(onco)逻辑支持的患者0例(术后19例)。术前n=3例(术后n=21例)进行体育活动/物理治疗。治疗前后的平均疼痛知觉为3/10。术后RS-11评分明显降低(p=0.01)。结论:促进口腔癌患者身心健康的支持性治疗措施是我们门诊住院治疗的一部分。然而,目前还没有对这些疗法进行标准化的监测。尽管在时间、成本和人员方面资源短缺,但在院前和住院治疗中提高身心健康的数字支持和标准化方案可能会改善结果的质量。微创气管插管管理和淋巴结管理治疗OCP可以帮助减少在重症监护病房的住院时间。
{"title":"Quality of outcome (QoO) in oral cancer patients: prospective perioperative analysis of patients' resilience and satisfaction during inpatient stay at a University Medical Centre in Germany.","authors":"Juliane Kröplin, Jil-Charlot Reppenhagen, Anke Hirsemann, Jan Liese, Bernhard Frerich","doi":"10.1515/iss-2024-0026","DOIUrl":"10.1515/iss-2024-0026","url":null,"abstract":"<p><strong>Objectives: </strong>Quality assurance strategies for head and neck surgery can improve patient outcomes. This study aims a perioperative analysis of indicators in the quality of outcome in oral cancer patients with special focus on patient`s resilience and satisfaction before and after surgery.</p><p><strong>Methods: </strong>Patients with oral cancer (OCP) and indication for surgical resection were included in a prospective study. General and disease-related data as well as parameters of patient-specific resilience (RS-11 questionnaire) and physical strength (ECOG-Score) were collected. Importance and satisfaction using the nine items family/friends, sports activities/physiotherapy, participation in culture, professional perspectives, sexuality, enjoyable food, external appearance, social recognition and independence were analysed. The data collection took place pre- and postoperatively (mean: 10th postop day) during the inpatient stay.</p><p><strong>Results: </strong>Twenty-eight patients with oral cancer (OCP) were analysed (male: n=23, female n=5). The rate of R0 resections was 92.6 %. The average length of stay was 21 days. n=16 of all patients was tracheotomised postop (preop: n=0). n=0 patients confirmed psycho(onco)logical support preop (postop: n=19). Sports activities/physiotherapy was provided to n=3 patients preop (postop: n=21). The mean pre and postop pain perception was 3/10. The RS-11 score decreased significantly postoperatively (p=0.01). A significant loss of satisfaction was seen in the areas of enjoyable food (p<0.001), social recognition (p=0.01), external appearance (p=0.01) and independence (p<0.001).</p><p><strong>Conclusions: </strong>Supportive therapy measures to promote mental and physical fitness of oral cancer patients are part of inpatient care at our clinic. However, there is no standardised monitoring of these therapies. Digitally supported and standardised programmes to increase mental and physical fitness in both prehospital and inpatient care might lead to an improvement in the quality of outcome despite shortage of resources in terms of time, costs and personnel. A minimally invasive approach to tracheal cannula management and lymph node management in the treatment of OCP can help to reduce the length of stay in the intensive care unit.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 3","pages":"143-150"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12552032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Augmented reality and optical navigation assisted orbital surgery: a novel integrated workflow. 增强现实和光学导航辅助眼眶手术:一种新的集成工作流程。
IF 1.2 Q2 SURGERY Pub Date : 2024-07-29 eCollection Date: 2025-06-01 DOI: 10.1515/iss-2023-0064
Nikolay Tonchev, Giulia Renieri, Klaus-Peter Stein, Belal Neyazi, Max Willgerodt, Hagen Thieme, I Erol Sandalcioglu, Karl Hartmann

Objectives: Due to the close topographical relationship of functional relevant anatomic structures, limited space and cosmetic aspects orbital surgery will remain a challenging discipline. Therefore, novel technical capabilities are necessary for further surgical progress. We here tested the integration of augmented reality and optical navigation in one workflow for interdisciplinary decision-making, feasibility and intraoperative guidance.

Methods: High-resolution contrast-enhanced MRI and CT scans were automated and manual-assisted segmented to achieve a detailed three-dimensional (3D) model of the individual patho-anatomical relationships. Augmented reality was used for interdisciplinary preoperative planning and intraoperative intuitive navigation. Mayfield clamp head holder in combination with optical surface matching registration assured navigation assisted microsurgery.

Results: Combinations of different MRI-sequences and CT-scans were necessary for detailed 3D-modeling. Modeling was time consuming and only viable in the hands of medical, surgical and anatomical trained staff. Augmented reality assured a quick, intuitive interdisciplinary orientation. Intraoperative surface matching registration enabled precise navigation in the orbital space.

Conclusions: Optical Navigation and microscope integration achieved a straightforward microsurgical workflow and should be implemented regularly. Augmented reality represented a useful tool for preoperative interdisciplinary planning and intraoperative intuitive orientation. It further stated an excellent educational tool.

目的:由于功能相关解剖结构的密切的地形关系,有限的空间和美容方面的眼眶手术将仍然是一个具有挑战性的学科。因此,新的技术能力对于进一步的手术进展是必要的。我们在这里测试了增强现实和光学导航在一个工作流程中的集成,用于跨学科决策,可行性和术中指导。方法:高分辨率增强MRI和CT扫描自动和人工辅助分割,以获得详细的个体病理解剖关系的三维(3D)模型。应用增强现实技术进行跨学科术前规划和术中直观导航。梅菲尔德钳头支架结合光学表面匹配注册保证导航辅助显微手术。结果:需要结合不同的mri序列和ct扫描进行详细的3d建模。建模是耗时的,只有在医疗、外科和解剖学训练有素的工作人员手中才可行。增强现实保证了快速、直观的跨学科方向。术中表面匹配配准实现了眼眶空间的精确导航。结论:光学导航与显微镜集成实现了简单的显微外科工作流程,应定期实施。增强现实是术前跨学科规划和术中直观定位的有用工具。它进一步说明了一个优秀的教育工具。
{"title":"Augmented reality and optical navigation assisted orbital surgery: a novel integrated workflow.","authors":"Nikolay Tonchev, Giulia Renieri, Klaus-Peter Stein, Belal Neyazi, Max Willgerodt, Hagen Thieme, I Erol Sandalcioglu, Karl Hartmann","doi":"10.1515/iss-2023-0064","DOIUrl":"10.1515/iss-2023-0064","url":null,"abstract":"<p><strong>Objectives: </strong>Due to the close topographical relationship of functional relevant anatomic structures, limited space and cosmetic aspects orbital surgery will remain a challenging discipline. Therefore, novel technical capabilities are necessary for further surgical progress. We here tested the integration of augmented reality and optical navigation in one workflow for interdisciplinary decision-making, feasibility and intraoperative guidance.</p><p><strong>Methods: </strong>High-resolution contrast-enhanced MRI and CT scans were automated and manual-assisted segmented to achieve a detailed three-dimensional (3D) model of the individual patho-anatomical relationships. Augmented reality was used for interdisciplinary preoperative planning and intraoperative intuitive navigation. Mayfield clamp head holder in combination with optical surface matching registration assured navigation assisted microsurgery.</p><p><strong>Results: </strong>Combinations of different MRI-sequences and CT-scans were necessary for detailed 3D-modeling. Modeling was time consuming and only viable in the hands of medical, surgical and anatomical trained staff. Augmented reality assured a quick, intuitive interdisciplinary orientation. Intraoperative surface matching registration enabled precise navigation in the orbital space.</p><p><strong>Conclusions: </strong>Optical Navigation and microscope integration achieved a straightforward microsurgical workflow and should be implemented regularly. Augmented reality represented a useful tool for preoperative interdisciplinary planning and intraoperative intuitive orientation. It further stated an excellent educational tool.</p>","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"10 2","pages":"91-98"},"PeriodicalIF":1.2,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12327852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144800492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Innovative Surgical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1